Drugmakers rushing to OTC price increase race

Published: 2009-03-17 07:00:00

Updated: 2009-03-17 07:00:00

Influenced by weakening domestic demand amid the deepening global economic downturn, the Korean OTC makers plan to increase the price of their flagship products despite concern over consumers’ antipathy.

Leading OTC products involved in the price increase hereafter include Donwha’s Hucidin oin...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK